NICOLE MONCRIEFFE: Open Payments
NPI 1487034666 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 7 payments from 7 companies in 2025. Trend: 2023 $47 · 2024 $671 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $109 |
| Eisai Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: Wegovy, Leqembi, INGREZZA, HETLIOZ, COBENFY, VRAYLAR, KISUNLA.
Industry payments across MD — which companies pay providers there.
